A Note from the President
Another year has gone by quickly and 2015 is right around the corner. This January marks our seven-year anniversary. It is hard to believe that eight years has passed since Pfizer R & D closed its doors in Ann Arbor, Michigan. January 22nd, 2007 was the announcement day that made all of us wonder what would happen after Pfizer. I was one of the lucky ones that had a plan shortly after the announcement and that plan was founding TransPharm Preclinical Solutions. We incorporated on April 13th, 2007, started renovation to the lab in September of that year, and opened our doors on January 2nd, 2008.
Today we are considered a global leader for Infectious Disease research and have generated more than 6 million in revenue with over 60 clients around the world. TransPharm has never been stronger and we are eager to see what the future holds for us. During the holidays, we are very thankful to do what we love and even more thankful to you for allowing us to do this important work.
President and CEO
Slight Increase in Pricing
Starting in January, TransPharm will be increasing the cost of our studies due to increases in costs from some of our suppliers. We expect the increase to be 5% across the board for all studies, but this could vary depending on study design. Studies booked for January that are scheduled in December will remain at the current price structure.
TransPharm will be closed from around noon on December 24th until January 5th. All studies must end no later than the 24th with preliminary data following mid-day. All mouse orders scheduled for January 5th must be placed before December 24th. No animals will be housed on-site during this closure. Now is the time to get your studies scheduled for the new year.